Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: Results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology

Journal of Clinical Oncology

Volumn 21, Issue 5, 2003, Pages 793-798

  Stewart, Richard J ^a   Martelli, Hélène ^a  

^a T Marciniak Lower Silesia Specialist Hospital Wroclaw   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT; IVA PROTOCOL; SIOP PROTOCOL;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; MESENCHYMOMA; ORCHIECTOMY; PRIORITY JOURNAL; REMISSION; RHABDOMYOSARCOMA; TESTIS CANCER; TUMOR VOLUME; INFANT; LYMPHADENECTOMY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PRESCHOOL CHILD; SALVAGE THERAPY; SURVIVAL RATE; TESTIS TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACTINOMYCIN; DISEASE-FREE SURVIVAL; HUMANS; IFOSFAMIDE; INFANT; LYMPH NODE EXCISION; MALE; MESENCHYMOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RHABDOMYOSARCOMA; SALVAGE THERAPY; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0037365851     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.06.040     Document Type: Article

References (21)

1. Raney RB Jr, Hays DM, Tefft M, et al: Rhabdomyosarcoma and the undifferentiated sarcomas, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology. Philadephia, PA, Lippincott-Raven Co, 1989, pp 635-658
2. Crist W, Gehan EA, Ragab AH, et al: The third Intergroup Rhabdomyosarcoma study. J Clin Oncol 13:610-630, 1995
3. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34:1050-1062, 1998
4. Crist WM, Anderson JR, Meza JL, et al: Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102, 2001
5. Ferrari A, Bisogno G, Casanova M, et al: Paratesticular rhabdomyosarcoma: Report from the Italian and German Cooperative Group. J Clin Oncol 20:449-455, 2002
6. Weiner ES, Anderson JR, Ojimba JI, et al: Controversies in the management of paratesticular rhabdomyosarcomas: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg 10:146-152, 2001
7. Olive D, Flamant F, Zucker JM, et al: Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma. Cancer 54:1283-1287, 1984
8. Hays DM, Lawrence W Jr, Wharam M, et al: Primary re-excision for patients with "microscopic residual" tumour following initial excision of sarcomas of trunk and extremity sites. J Pediatr Surg 24:5-10, 1989
9. Newton WA, Gehan EA, Weber BL, et al: Classification of rhabdomyosarcomas and related sarcomas: Pathologic aspects and proposal for a new classification. An Intergroup Rhabdomyosarcoma Study. Cancer 76:1073-1085, 1995
10. Rodary C, Flamant F, Donaldson SS: An attempt to use a common staging system in rhabdomyosarcoma: A report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP). Med Pediatr Oncol 17:210-215, 1989
11. Martelli H, Oberlin O, Rey A, et al: Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the study committee of the International Society of Paediatric Oncology. J Clin Oncol 17:2117-2122, 1999
12. Kaplan ES, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481, 1958
13. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1-39, 1977
14. Heyn R, Raney RB Jr, Hays DM, et al: Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 10:614-623, 1992
15. Hughes LL, Baruzzi MJ, Ribeiro RC, et al: Paratesticular rhabdomyosarcoma: Delayed effects of multimodality therapy and implications for current management. Cancer 73:467-482, 1994
16. Jewett MA: Nerve-sparing technique for retroperitoneal lymphadenectomy in testis cancer. Urol Clin North Am 17:449-456, 1990
17. Janetsche G, Hobisch A, Peschel R, et al: Laparoscopic retroperitoneal lymph node dissection of clinical stage 1 nonseminomatous testicular carcinoma: Long term outcome. J Urol 163:1793-1796, 2000
18. Cecchetto G, Grotto P, De Bernardi B, et al: Paratesticular rhabdomyosarcoma in childhood: Experience of the Italian Cooperative Study. Tumori 74:645-647, 1988
19. Gamba PG, Cecchetto G, Katende M, et al: Paratesticular rhabdomyosarcoma (RMS) and paraaortic lymphadenectomy. Eur J Pediatr Surg 4:158-160, 1994
20. Wiener ES, Lawrence W, Hays D, et al: Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. J Pediatr Surg 29:171-178, 1994
21. Dall'Igna P, Cecchetto G, Carli M, et al: Primary transcrotal excision for paratesticular RMS: Is hemiscrotectomy really mandatory? Med Pediatr Oncol 37:344, 2001